BD announces dividend and additional share repurchase authorization
FRANKLIN LAKES, N.J. - BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology firm with a market capitalization of $72.47 billion, declared a quarterly dividend and the ...
BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases BD Completed $750 Million Repurchase To Date In FY25
The company also announced it repurchased $750 million in BD stock to date in fiscal 2025. In addition, the board has authorized the company to repurchase up to 10 million shares of BD common stock in ...
Le Lézard14h
Point of Care Diagnostics Market to Hit USD 22.63 Billion by 2029 with 8.5% CAGR | MarketsandMarketstm
The global point of care diagnostics market valued at US$ 14.26 billion in 2023, is forecasted to grow at a robust CAGR of 8.5%, reaching US$ 15.05 billion in 2024 and an impressive US$ 22.63 billion ...
Piper Sandler raises Becton Dickinson stock target to $280
Piper Sandler's analysts increased the price target for Becton Dickinson (NYSE:BDX) shares to $280 from $275, while ...
Future Market Insights16h
Lateral Flow Assay Industry to Reach USD 6.9 Billion by 2033, Growing at a 4.7% CAGR Due to Rising Demand for Rapid and Cost-Effective Diagnostics
The global lateral flow assay (LFA) market, valued at USD 4.3 billion in 2023, is projected to grow steadily at a CAGR of 4.7 ...